The antimalarial efficacy and mechanism of resistance of the novel chemotype DDD01034957

New antimalarial therapeutics are needed to ensure that malaria cases continue to be driven down, as both emerging parasite resistance to frontline chemotherapies and mosquito resistance to current insecticides threaten control programmes. Plasmodium, the apicomplexan parasite responsible for malari...

Descripción completa

Detalles Bibliográficos
Autores principales: Miguel-Blanco, Celia, Murithi, James M., Benavente, Ernest Diez, Angrisano, Fiona, Sala, Katarzyna A., van Schalkwyk, Donelly A., Vanaerschot, Manu, Schwach, Frank, Fuchter, Matthew J., Billker, Oliver, Sutherland, Colin J., Campino, Susana G., Clark, Taane G., Blagborough, Andrew M., Fidock, David A., Herreros, Esperanza, Gamo, Francisco Javier, Baum, Jake, Delves, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820608/
https://www.ncbi.nlm.nih.gov/pubmed/33479319
http://dx.doi.org/10.1038/s41598-021-81343-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820608/
https://www.ncbi.nlm.nih.gov/pubmed/33479319
http://dx.doi.org/10.1038/s41598-021-81343-z

Ejemplares similares